Structural Biology in the RFI
In plain English
AI plain-English summaryA consortium of ten UK universities, central facilities, and industry partners is building new tools to see the inner workings of biological molecules in unprecedented detail. The problem is that current methods for imaging proteins and other biomolecules are too slow, too static, or too limited in scale. Many of the molecules most relevant to drug discovery and biotechnology—large, transient assemblies or unstructured proteins—remain invisible to existing techniques. This gap blocks progress in designing new pharmaceuticals, industrial enzymes, and agricultural chemicals. If the research succeeds, it will transform how drugs are discovered. Fragment-based drug discovery pipelines will become faster and more reliable. New hardware for electron microscopes and tomographs will capture molecules in motion, not just static snapshots. Combining imaging data from different sources will reveal how proteins change shape over time—the fourth dimension of structural biology. The project is applied, not fundamental curiosity-driven research. Its explicit goal is to deliver practical breakthroughs for the life sciences sector, from pharmaceutical development to industrial biotechnology. The payoff is a new generation of imaging infrastructure that lets researchers see what has been invisible, and use that sight to engineer better medicines and materials.
View original technical description
View the original record at the funder ↗
Researchers
Original classification
Research GrantPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know